< LEADERBOARD/s/collagenProteins & connective tissue

Collagen

Also sold as: Collagen peptides · Hydrolyzed collagen · Undenatured type II collagen

Animal-derived protein peptides studied for modest skin and joint effects. Hydrolysates and undenatured type II collagen have different mechanisms and are not interchangeable by weight.

Longevity

COMMUNITY_STACK_RATINGlive · n=0

Community

Not enough ratings yet: 0 of 10

Scores appear after 10 ratings, so that one or two reports can't dominate. Tried it? Your rating counts.

+ Rate your experience (30 sec, anonymous)

NERD_PROTOCOL // EVIDENCE_MATRIXper goal

Research

  • Longevity: Skin appearance and joint symptoms do not demonstrate slower biological aging or longer life; no longevity benefit is established.

REALITY CHECK // Collagen is not an anti-aging shortcut. Small cosmetic and joint benefits are plausible, but industry funding and conflicting knee subscale results reduce certainty. No human gut-healing or migraine benefit is established, and 40 mg UC-II is not equivalent to grams of hydrolysate.

Levels: how we grade evidence. Grey = evidence of no benefit; amber = evidence it makes this goal worse.

Ratings are self-reported by a self-selected group of users: how it felt, not proof that it works.

CHECK_YOUR_BOTTLE.EXEruns in your browser · nothing is sent or stored

Check your bottle

Compare what your label says with what was used in trials. This is a trial range, not a personal prescription.

Try a common label:
The label number is the…

Enter the amount from your label to see the result.

How it was studied

01 // STUDIED_DOSE_RANGE
UC-II around 40 mg/day
Hydrolysate doses vary; an adequately documented per-indication range is unavailable in this source.
02 // TIMING_&_MATRIX
Loading context matters
Vitamin C plus collagen around an hour before tendon loading was studied mechanistically; it does not prove an obligatory daily timing rule.
03 // EVALUATION_WINDOW
8–24 weeks
Skin trials commonly lasted 8–12 weeks and knee trials 8–24 weeks; bone outcomes require much longer follow-up.
04 // SAFETY_&_QUALITY_GATE
Source and additives
Check animal-source allergy and blend ingredients, especially vitamin K with anticoagulants.

UPPER LIMIT // No formal EFSA or NIH UL is supplied for collagen. Absence of a UL is not unlimited-dose safety. Total protein intake and individual renal or metabolic conditions matter.

NERD'S NOTENerd Protocols · a clinical and sports dietitian based in the EU

Summary

Skin hydration and knee symptoms have trial signals, but effects are modest and many studies are manufacturer funded. Knee meta-analyses disagree on pain and function subscales. Tendon and training findings are promising with lower certainty, and collagen does not replace complete dietary protein.

Mechanism

Hydrolysates supply amino acids and short peptides; human blood studies detect absorbed collagen-derived peptides. UC-II instead aims at oral immune tolerance and is studied at much smaller product amounts. Acute synthesis markers do not prove long-term tendon repair.

Typical studied dose

UC-II trials used approximately 40 mg/day product. The dossier discusses gram-dose hydrolysates but does not supply a verified indication-by-form dose interval, so no universal hydrolysate calculator target is assigned. Skin studies commonly ran 8–12 weeks; joint studies 8–24 weeks; one bone study lasted 12 months.

Upper limit

No formal EFSA or NIH UL is supplied for collagen. Absence of a UL is not unlimited-dose safety. Total protein intake and individual renal or metabolic conditions matter.

POPULAR_STACKScombos with n ≥ 5

Popular stacks with Collagen

Not enough stack data yet. A combination with Collagen appears here once 5 people rate the same set.

> Rate my stack

Forms and label traps

Forms compared
Form on labelActive contentStudied range / dayAbsorption & GI toleranceVerdict
Hydrolyzed collagen peptides
Best for: Evaluating actual collagen peptide mass.
Unstandardized: active content unknown no comparable trial range Human blood contains collagen-derived peptides after ingestion; this does not mean intact collagen travels directly to a joint.
Usually good; larger amounts may cause gastrointestinal discomfort.
Studied standard [FORM // REFERENCE]
100% denotes a pure peptide ingredient, not efficacy or absorbed percentage. Dose interval is unavailable in the dossier; 0/0 prevents a false universal target.
Undenatured type II collagen product (UC-II)
Best for: Matching a studied joint-specific product.
Extract weight · marker not quantified 40–40 mg Oral immune-tolerance mechanism; not a bulk amino-acid substrate.
Generally tolerated in the trials.
Good option [FORM // CHECK_LABEL]
40 mg refers to the studied product, not 40 mg purified active type II antigen; marker fraction is not supplied.
Marine-derived hydrolyzed collagen
Best for: People avoiding bovine ingredients who tolerate fish.
Unstandardized: active content unknown no comparable trial range Marine source does not establish clinically superior absorption to bovine products.
Usually tolerated except for relevant source allergy.
Caution [FORM // CHECK_LABEL]
Count actual peptide ingredient mass; no substantiated marine-to-bovine potency conversion is supplied.
Gelatin or native culinary collagen
Best for: Food ingredient comparison.
Unstandardized: active content unknown no comparable trial range Requires digestive breakdown; culinary use is not UC-II or a specified hydrolysate.
Generally tolerated as food.
Caution [FORM // CHECK_LABEL]
No validated calculator conversion to a clinical hydrolysate or UC-II protocol.

Common label traps

  • TRAP_01 // Collagen stops being made after age 21
    Endogenous production does not abruptly stop. Modest skin outcomes are not reversal of aging.
  • TRAP_02 // Collagen cannot be absorbed
    Short peptides are detectable in human blood, but that does not prove every claimed skin, tendon or gut benefit.
  • TRAP_03 // Marine collagen is necessarily stronger and UC-II is just a tiny hydrolysate dose
    Source alone does not establish potency. UC-II and hydrolysates use different mechanisms and weight scales.

Other outcomes studied

Outside the five leaderboard goals. Same evidence levels as above.

  • SKIN HYDRATION / WRINKLES Moderate · benefit
    A 19-RCT review with 1,341 participants reports modest wrinkle and hydration effects; elasticity and density results are inconsistent. The aggregate combines oral and topical peptide evidence, so results require formulation-specific interpretation.
    PMID 41924746 PMID 29949889 PMID 32799362
  • KNEE OA: UPDATED REVIEW Moderate · benefit
    The updated 11-RCT review with 870 participants reports pain MD -13.63 (95% CI -20.67 to -6.58) and function MD -6.46 (-9.52 to -3.40). Scales and products differ; these are not universal symptom-percentage reductions.
    PMID 39212129 PMID 26822714
  • KNEE OA: EARLIER CONFLICT Limited · no benefit
    The earlier review improved total WOMAC (WMD -8.00, 95% CI -13.04 to -2.95) but did not find significant pain or function subscale effects (p=0.75 and p=0.81).
    PMID 30368550
  • TRAINING / BODY COMPOSITION Moderate · benefit
    A 19-study synthesis with 768 participants reports fat-free mass SMD 0.48, muscle architecture 0.39 and maximal strength 0.19, with training over at least 8–12 weeks. Collagen is incomplete protein and not a substitute for complete protein intake.
    PMID 39060741 PMID 26353786
  • TENDONS / ACHILLES Limited · benefit
    Tendon morphology SMD 0.67 had very low certainty; small trials combine peptides with loading or calf exercise. An acute synthesis signal does not establish tendon healing.
    PMID 39060741 PMID 30609761 PMID 35403756 PMID 40623147
  • BONE DENSITY Limited · benefit
    A 12-month trial in postmenopausal women with osteopenia found a spinal BMD signal; another calcium/vitamin-D combination trial was mixed. No replacement for osteoporosis care.
    PMID 29337906 PMID 34980546
  • 48-HOUR EXERCISE RECOVERY Limited · benefit
    Reactive-strength recovery SMD 0.43 at 48 hours (p=0.045) is a small, low-certainty signal.
    PMID 39060741 PMID 39408370
  • CELLULITE Limited · benefit
    Small industry-associated studies suggest cosmetic changes, partly dependent on BMI; clinical significance and generalizability are uncertain.
    PMID 26561784 PMID 41788055
  • WOUND HEALING No established evidence
    Mechanistic review evidence does not establish faster wound healing in healthy humans; this denotes unestablished benefit, not a negative clinical trial.
    PMID 39405278
  • HAIR / NAILS Limited · benefit
    Dedicated evidence is sparse; some nail findings are secondary skin-trial outcomes. No reliable broad hair-growth claim is established.
    PMID 40176998 PMID 39143887
  • GUT BARRIER No established evidence
    Cell and mouse barrier studies are preclinical. Human gut-healing efficacy is unestablished rather than disproven in an RCT.
    PMID 28174772 PMID 31370332 PMID 39514440
  • MIGRAINE No established evidence
    No relevant oral-collagen migraine studies are supplied; gene-related vascular papers are off-topic, not evidence.

Reader questions

Is 40 mg UC-II weaker than 10 g peptides?

Those amounts cannot be compared as potency. UC-II targets oral immune tolerance; hydrolysates provide peptides and amino-acid substrate.

Should I take 2.5, 5, 10 or 14 g?

The dossier does not give an adequately sourced dose-by-indication interval. These common consumer amounts should not be treated as equivalent to every clinical product.

Does it help hair, nails and the gut?

Nail evidence is limited and sometimes secondary; a general hair claim is not established. Gut-barrier findings here are cells or mice, not human efficacy trials.

Can it cause sleepiness or lower blood pressure?

Sleepiness and brain fog are user reports, not established trial rates; this dossier does not establish a blood-pressure effect. Persistent dizziness or near-fainting needs assessment.

Stack interactions

  • Caution Vitamin K-containing collagen blends with warfarin [CAUTION // REVIEW_CONTEXT]
    The interaction concern is added K1/K2, not plain collagen. Review the full label and vitamin K antagonist regimen with the prescriber.
  • Caution Vitamin C and tendon-loading exercise [CAUTION // REVIEW_CONTEXT]
    Vitamin C is a hydroxylation cofactor; the dossier describes an acute pre-loading synthesis study. This is not proof that adding vitamin C always improves long-term outcomes.
  • Caution UC-II and immunosuppressants [CAUTION // REVIEW_CONTEXT]
    Immune modulation motivates a theoretical precaution; no clinical harm interaction is documented here.
  • Caution Glycine and calming stacks [CAUTION // REVIEW_CONTEXT]
    Collagen contains substantial glycine; drowsiness or brain fog is anecdotal and has no established frequency or proven stack interaction.

Red flags: interactions and who should avoid it

Interactions

Plain collagen is not a vitamin K source, but K1/K2 added to blends may interfere with warfarin or other vitamin K antagonists. UC-II with immunosuppressants is a theoretical precaution, not a documented interaction. Vitamin C is a synthesis cofactor; joint-stack synergy is not established.

Avoid or ask a doctor first if

Check fish, bovine and other source allergies. Phenylketonuria requires protein planning; kidney disease warrants review of total protein intake. Pregnancy and lactation data are limited. Nausea, reflux or diarrhea can occur; user reports of drowsiness or brain fog are anecdotal.

Sources (PubMed, 25)

  1. Oral and topical peptides for skin aging: systematic review and meta-analysis of randomized controlled trials.
    PMID 41924746 · 2026 · systematic review and meta-analysis
    Peptide skin-aging review; oral and topical evidence must be distinguished.
  2. Oral Intake of Low-Molecular-Weight Collagen Peptide Improves Hydration, Elasticity, and Wrinkling in Human Skin: A Randomized, Double-Blind, Placebo-Controlled Study.
    PMID 29949889 · 2018 · randomized controlled trial
    Oral low-molecular-weight peptide skin RCT.
  3. A randomized, triple-blind, placebo-controlled, parallel study to evaluate the efficacy of a freshwater marine collagen on skin wrinkles and elasticity.
    PMID 32799362 · 2021 · randomized controlled trial
    Marine collagen skin trial.
  4. Effect of collagen supplementation on knee osteoarthritis: an updated systematic review and meta-analysis of randomised controlled trials.
    PMID 39212129 · 2025 · systematic review and meta-analysis
    Updated knee-OA review with favorable pain and function estimates.
  5. Effect of collagen supplementation on osteoarthritis symptoms: a meta-analysis of randomized placebo-controlled trials.
    PMID 30368550 · 2019 · systematic review and meta-analysis
    Earlier OA review with null pain and function subscales despite improved total WOMAC.
  6. Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study.
    PMID 26822714 · 2016 · randomized controlled trial
    Undenatured type II product knee-OA RCT.
  7. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial.
    PMID 19847319 · 2009 · randomized controlled trial
    Earlier undenatured type II knee-OA trial.
  8. Impact of Collagen Peptide Supplementation in Combination with Long-Term Physical Training on Strength, Musculotendinous Remodeling, Functional Recovery, and Body Composition in Healthy Adults: A Systematic Review with Meta-analysis.
    PMID 39060741 · 2024 · systematic review and meta-analysis
    Training meta-analysis covering body composition, strength, tendons and recovery.
  9. Collagen peptide supplementation in combination with resistance training improves body composition and increases muscle strength in elderly sarcopenic men: a randomised controlled trial.
    PMID 26353786 · 2015 · randomized controlled trial
    Collagen plus resistance training in older sarcopenic men.
  10. Oral Supplementation of Specific Collagen Peptides Combined with Calf-Strengthening Exercises Enhances Function and Reduces Pain in Achilles Tendinopathy Patients.
    PMID 30609761 · 2019 · randomized controlled trial
    Peptides plus calf exercise in Achilles tendinopathy.
  11. Effects of specific collagen peptide supplementation combined with resistance training on Achilles tendon properties.
    PMID 35403756 · 2022 · randomized controlled trial
    Peptides plus resistance training and Achilles properties.
  12. Collagen Peptide Supplementation Enhances Muscle-Tendon Stiffness and Explosive Strength: A 16-wk Randomized Controlled Trial.
    PMID 40623147 · 2025 · randomized controlled trial
    Sixteen-week muscle-tendon and explosive-strength trial.
  13. Specific Collagen Peptides Improve Bone Mineral Density and Bone Markers in Postmenopausal Women-A Randomized Controlled Study.
    PMID 29337906 · 2018 · randomized controlled trial
    Bone-density trial in postmenopausal women.
  14. Effect of Calcium and Vitamin D Supplementation With and Without Collagen Peptides on Volumetric and Areal Bone Mineral Density, Bone Geometry and Bone Turnover in Postmenopausal Women With Osteopenia.
    PMID 34980546 · 2022 · randomized controlled trial
    Mixed bone results with calcium/vitamin D and optional peptides.
  15. The Effects of Collagen Peptides as a Dietary Supplement on Muscle Damage Recovery and Fatigue Responses: An Integrative Review.
    PMID 39408370 · 2024 · systematic review and meta-analysis
    Integrative review of muscle-damage recovery and fatigue.
  16. Dietary Supplementation with Specific Collagen Peptides Has a Body Mass Index-Dependent Beneficial Effect on Cellulite Morphology.
    PMID 26561784 · 2015 · randomized controlled trial
    BMI-dependent cellulite morphology trial.
  17. Low-Molecular-Weight Collagen Peptide Supplementation Improves Cellulite Severity, Skin Elasticity, and Hair Shaft Diameter: A Clinical Study with Pharmacokinetic Evaluation.
    PMID 41788055 · 2026 · randomized controlled trial
    Small cosmetic cellulite and hair-shaft study.
  18. Deciphering the Wound-Healing Potential of Collagen Peptides and the Molecular Mechanisms: A Review.
    PMID 39405278 · 2024 · narrative review
    Mechanistic wound-healing review rather than proof of healthy-human healing.
  19. Nail Supplements: When, How, and Why?
    PMID 40176998 · 2025 · narrative review
    Review emphasizing limited nail-supplement evidence.
  20. Influence of collagen peptide supplementation on visible signs of skin and nail health and -aging in an East Asian population: A double blind, randomized, placebo-controlled trial.
    PMID 39143887 · 2024 · randomized controlled trial
    Skin trial including nail outcomes.
  21. Collagen peptides ameliorate intestinal epithelial barrier dysfunction in immunostimulatory Caco-2 cell monolayers via enhancing tight junctions.
    PMID 28174772 · 2017 · in vitro study
    Caco-2 cell barrier experiment.
  22. Identification and Structure-Activity Relationship of Intestinal Epithelial Barrier Function Protective Collagen Peptides from Alaska Pollock Skin.
    PMID 31370332 · 2019 · in vitro study
    Preclinical peptide barrier study.
  23. The Hydrophobic Amino Acid-Rich Fish Collagen Peptide Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice via Repairing the Intestinal Barrier, Regulating Intestinal Flora and AA Metabolism.
    PMID 39514440 · 2024 · animal study
    Mouse colitis model, not human gut-healing evidence.
  24. Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates.
    PMID 16076145 · 2005 · clinical or mechanistic study
    Human blood detection of food-derived peptides.
  25. Hydrolyzed Marine Collagen: Emerging Evidence of Benefits via the Oral Route - Review and Insights for Medical Aesthetics Practitioners.
    PMID 41393269 · 2025 · narrative review
    Narrative review of oral marine-collagen evidence.

Community comments

No approved comments yet. Comments are held for moderation.

+ Rate this